Pfizer Whistleblower Exposes Compromised Vaccine Trial Data
A regional director for Pfizer employed at the Ventavia Research Group tells BMJ that Pfizer falsified vaccine data, unblinded patients, and hired inadequately trained vaccine administrators.
Pfizer was also said to be slow following up on adverse reactions from the vaccine.
After notifying the research group of these problems repeatedly Brook Jackson, regional director, notified the FDA in an email.
Ventavia fired her that day.
In an email to the FDA sent September 25th, Jackson said that Ventavia enrolled more than 1000 participants at three sites. The full trial registered 44,000 participants across 153 sights.
Here were some of the complaints she listed:
Participants placed in a hallway after injection and not being monitored by clinical staff
Lack of timely follow-up of patients who experienced adverse events
Protocol deviations not being reported
Vaccines not being stored at proper temperatures
Mislabelled laboratory specimens, and
Targeting of Ventavia staff for reporting these types of problems.
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Other anonymous employees reported similar complaints as Jackson.